BioUtah News
-
ARUP Achieves Reaccreditation Under College of American Pathologists ISO 15189 Program
ARUP Achieves Reaccreditation Under College of American Pathologists ISO 15189 Program
-
Altesa BioSciences and bioMérieux Announce Collaboration for Altesa’s Upcoming Phase 2B COPD Clinical Trial
Study will begin enrollment in Q1 2026 in the US and UK and leverage the BIOFIRE® SPOTFIRE® point-of-care…
-
Owlet Makes Premium Monitoring Possible for Every Family With New Dream Sight™ Video Monitor
Owlet’s new release creates the ultimate baby monitoring system for video, sleep, and medical-grade health tracking.
-
BioUtah Member Appreciation BBQ 2025 Recap
BioUtah Member Appreciation BBQ 2025 Recap
-
Kimbell & Associates: Trump Administration Issues MAHA Strategy Report of Recommendations to President Trump
Kimbell & Associates: Trump Administration Issues MAHA Strategy Report of Recommendations to President Trump
-
Arcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Cream 0.3% to Expand Indication for Treatment of Plaque Psoriasis in Children Ages 2 to 5
If approved, ZORYVE cream would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in…
-
Salt Lake City Angels Invests in Freyya
Salt Lake City Angels Invests in Freyya
-
Owlet Extends Global Reach with Launch of Medically-Certified Dream Sock™ to South Africa
The wearable baby monitor trusted by millions globally expands reach to three continents, including North America, Europe, and…
-
Legendary Scientist and Biotech Veteran Joins CancerVax as Strategic Advisor
Dr. Gordon Ringold to advise on various strategies related to the development of the Company’s novel cancer treatment…
-
BD Expands Peripheral Artery Disease Awareness Efforts with ‘Love Your Limbs’ Community Screening Initiative
BD Expands Peripheral Artery Disease Awareness Efforts with ‘Love Your Limbs’ Community Screening Initiative
-
PhotoPharmics Forms Commercial Advisory Board to Guide Market Launch of Breakthrough Parkinson’s Therapy
Renowned leaders in neurology, movement disorders, and commercialization join to shape Celeste® market strategy
-
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss
Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
